D.J. St. Germain’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $267K | Sell |
2,116
-608
| -22% | -$80.1K | 0.01% | 283 |
|
|
2026
Q1 | $380K | Sell |
2,724
-27
| -1% | -$3.78K | 0.02% | 239 |
|
|
2025
Q4 | $338K | Buy |
2,751
+11
| +0.4% | +$1.34K | 0.01% | 257 |
|
|
2025
Q3 | $304K | Sell |
2,740
-355
| -11% | -$40.4K | 0.01% | 266 |
|
|
2025
Q2 | $343K | Buy |
3,095
+172
| +6% | +$18.3K | 0.01% | 245 |
|
|
2025
Q1 | $328K | Sell |
2,923
-92
| -3% | -$9.49K | 0.02% | 239 |
|
|
2024
Q4 | $278K | Sell |
3,015
-571
| -16% | -$51.4K | 0.01% | 262 |
|
|
2024
Q3 | $301K | Hold |
3,586
| – | – | 0.01% | 239 |
|
|
2024
Q2 | $246K | Hold |
3,586
| – | – | 0.01% | 244 |
|
|
2024
Q1 | $263K | Sell |
3,586
-123
| -3% | -$9.46K | 0.01% | 245 |
|
|
2023
Q4 | $300K | Sell |
3,709
-230
| -6% | -$17.9K | 0.02% | 231 |
|
|
2023
Q3 | $295K | Hold |
3,939
| – | – | 0.02% | 221 |
|
|
2023
Q2 | $304K | Buy |
+3,939
| New | +$314K | 0.02% | 222 |
|
|
2022
Q4 | $28.7K | Buy |
4,246
+560
| +15% | +$44.3K | 0.01% | 203 |
|
|
2022
Q3 | $228K | Hold |
3,686
| – | – | 0.02% | 217 |
|
|
2022
Q2 | $228K | Hold |
3,686
| – | – | 0.02% | 217 |
|
|
2022
Q1 | $219K | Sell |
3,686
-238
| -6% | -$15.2K | 0.01% | 230 |
|
|
2021
Q4 | $285K | Sell |
3,924
-442
| -10% | -$30.4K | 0.02% | 211 |
|
|
2021
Q3 | $305K | Sell |
4,366
-175
| -4% | -$12.3K | 0.02% | 201 |
|
|
2021
Q2 | $313K | Hold |
4,541
| – | – | 0.02% | 206 |
|
|
2021
Q1 | $293K | Sell |
4,541
-539
| -11% | -$34.8K | 0.02% | 199 |
|
|
2020
Q4 | $296K | Sell |
5,080
-4,428
| -47% | -$267K | 0.02% | 200 |
|
|
2020
Q3 | $601K | Sell |
9,508
-75
| -0.8% | -$5.2K | 0.05% | 124 |
|
|
2020
Q2 | $737K | Sell |
9,583
-65
| -0.7% | -$4.98K | 0.06% | 118 |
|
|
2020
Q1 | $721K | Sell |
9,648
-1,876
| -16% | -$130K | 0.07% | 119 |
|
|
2019
Q4 | $749K | Buy |
11,524
+6,568
| +133% | +$428K | 0.06% | 129 |
|
|
2019
Q3 | $314K | Sell |
4,956
-310
| -6% | -$20.3K | 0.03% | 155 |
|
|
2019
Q2 | $356K | Sell |
5,266
-750
| -12% | -$49.3K | 0.04% | 142 |
|
|
2019
Q1 | $391K | Sell |
6,016
-811
| -12% | -$53.9K | 0.04% | 135 |
|
|
2018
Q4 | $427K | Buy |
6,827
+1,060
| +18% | +$74.1K | 0.05% | 124 |
|
|
2018
Q3 | $445K | Buy |
5,767
+1,866
| +48% | +$141K | 0.05% | 122 |
|
|
2018
Q2 | $276K | Buy |
3,901
+403
| +12% | +$28.5K | 0.03% | 143 |
|
|
2018
Q1 | $264K | Hold |
3,498
| – | – | 0.03% | 142 |
|
|
2017
Q4 | $251K | Sell |
3,498
-495
| -12% | -$37.6K | 0.03% | 138 |
|
|
2017
Q3 | $324K | Sell |
3,993
-13
| -0.3% | -$994 | 0.04% | 117 |
|
|
2017
Q2 | $284K | Buy |
4,006
+265
| +7% | +$17.6K | 0.04% | 123 |
|
|
2017
Q1 | $254K | Buy |
+3,741
| New | +$263K | 0.04% | 125 |
|
|
2016
Q4 | – | Sell |
-8,688
| Closed | -$687K | – | 140 |
|
|
2016
Q3 | $687K | Buy |
8,688
+647
| +8% | +$52.6K | 0.1% | 85 |
|
|
2016
Q2 | $671K | Buy |
8,041
+620
| +8% | +$55K | 0.09% | 91 |
|
|
2016
Q1 | $682K | Buy |
7,421
+1,996
| +37% | +$180K | 0.1% | 86 |
|
|
2015
Q4 | $549K | Buy |
+5,425
| New | +$564K | 0.08% | 86 |
|
Other funds holding GILD
D.J. St. Germain's GILD Position: Q2 2026 in Review
D.J. St. Germain reduced its Gilead Sciences (GILD) stake by 22% in Q2 2026, selling an estimated $80.1K and leaving 2,116 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #283.
D.J. St. Germain first reported a position in GILD in Q4 2015 and has held it in 41 quarters since. The position peaked at $749K in Q4 2019. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- D.J. St. Germain held 2,116 shares of Gilead Sciences worth $267K as of Q2 2026.
- D.J. St. Germain sold 608 Gilead Sciences shares in Q2 2026, an estimated $80.1K.
- Gilead Sciences made up 0.01% of D.J. St. Germain's portfolio in Q2 2026, its #283 holding.
- D.J. St. Germain first reported a position in Gilead Sciences in Q4 2015 and has held it in 41 quarters since.
- D.J. St. Germain's Gilead Sciences position peaked at $749K in Q4 2019.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.